U.S. Trade Agreement Talks On Drug Pricing Shift To G-8 Nations
This article was originally published in The Pink Sheet Daily
Executive Summary
Administration’s focus "is primarily on the G-8 countries" following a bilateral agreement with Australia that increases transparency in drug reimbursement determinations, U.S. Trade Rep. Zoellick tells Senate Finance Committee.